Stock screener

VNDA

Conviction 20HealthcareScan · Fri, Oct 2, 2026

Vanda Pharmaceuticals Inc. (VNDA) closed at $4.63 (-3.74%) on Oct 2, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 33, RS Rating 43, -51.7% from its 52-week high, -44.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

VNDA$4.63-3.74%
ResistanceSupportVol 14
63 bars
Vol MA14 1.21M
Jul 7Jul 23Aug 11Aug 27Sep 16Oct 2
Vanda Pharmaceuticals Inc.PHARMACEUTICAL PREPARATIONSwww.vandapharma.com ↗
Price4.63
Change-3.74%
Gap+0.21%
Rel volume2.82×
Avg volume1.14M
Avg $ vol5.71M
SMA 205.07
SMA 505.18
SMA 2006.53
Price vs 50-10.81%
Price vs 200-29.27%
MA stackbearish
50/200 cross—
Supertrenddown · 5.29
RSI (14)33
MACD hist-0.04
MACD crossbear · 3d
Stoch %K / %D7 / 4
ADX (14)20
+DI / −DI12 / 28
RSI divergenceBullish
MACD divergenceBullish
ATR %4.30%
ADR %3.49%
52w high9.56
52w low4.32
From 52w high-51.67%
Above 52w low+6.94%
New 52w highNo
SqueezeOff
Bollinger width13.62%
%B-0.16
Donchian pos6.21%
Donchian high5.45
Donchian low4.57
AVWAP (52w high)6.39
vs AVWAP high-27.70%
AVWAP (52w low)7.02
vs AVWAP low-34.17%
OBV trendDown
Chaikin MF (20)-0.24
Today vs 20d2.82×
Avg vol (14d)1.32M
Avg vol (20d)1.14M
Avg $ vol (20d)5.71M
Market cap279.34M
RS Rating43 / 99
RS 3m (vs SPY)-28.29%
RS 6m (vs SPY)-51.36%
RS line new highNo
Trend template0/8
Technical rank17.9
1 week-8.51%
1 month-16.46%
3 months-25.84%
6 months-34.00%
1 year-9.41%
YTD-44.00%
P/E-1.27
P/B1.27
P/S1.29
P/FCF-2.53
EPS-3.74
Div yield—
ROE-100.13%
ROA-53.45%
Debt/Eq—
Current1.61
EV/EBITDA-1.48
Gross margin28.17%
Net margin-102.02%
Rev growth8.72%
EPS growth-1066.53%
Price target13.25
Target upside186.80%
Analyst ratingBuy
Institutional90.44%
Ent. value223.46M
Revenue50.53M
Net income-62.51M
Gross profit—
Free cash flow-110.44M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out60.14M
Employees533
ListedWed, Apr 12, 2006
Free float51.85M
Float %87.7%
Short interest7.69M
Days to cover9.9d
Short volume62.0%
Squeeze score84 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.04 vs −$0.51
Last surprise-103.9% miss
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank17.9 / 100
Group rank14 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.62
Support4.94
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in VNDA

All disclosures →
No recent disclosed trades by Congress in VNDA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VNDA

InsiderSideShares
Mitchell Stephen Ray
Director · Common Stock · 2026-06-04
Grant41.6K
Chrousos Phaedra
Director · Common Stock · 2026-06-04
Grant41.6K
Ward Anne Sempowski
Director · Common Stock · 2026-06-04
Grant41.6K
Honore Tage
Director · Common Stock · 2026-06-04
Grant41.6K
DUGAN RICHARD W
Director · Common Stock · 2026-06-04
Grant41.6K
Duncan Charles Cliff
Director · Common Stock · 2026-06-04
Grant41.6K
McGuire Daniel Patrick
SVP, GC and Secretary · Common Stock · 2026-06-04
Grant80K
Mitchell Stephen Ray
Director · Common Stock · 2026-05-18
Gift25.84K
Duncan Charles Cliff
Director · Common Stock · 2026-04-22
Grant57.1K

SEC filings

EDGAR filings in VNDA · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.